Commission Implementing Regulation (EU) 2021/52 [Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 23, 25.1.2021, p. 13).] extended the approval period of the active substances dimoxystrobin, mecoprop-P, metiram, oxamyl and pyraclostrobin until 31 January 2022, and the approval period of the active substances benfluralin, fluazinam, flutolanil and mepiquat until 28 February 2022.
Recital 2, Regulation (EU) 2021/2068
In forcesince 25 Nov 2021